Regulations for the development of biosimilar

Journal Title: World Journal of Pharmaceutical Sciences - Year 2016, Vol 4, Issue 11

Abstract

Present article signifies the exigency for robust regulation involved in the development of biosimilars. The principle for the development of biosimilars included opting adequate reference product, manufacturing process optimisation, quality control procedure, preclinical and clinical studies. India’s first guidelines were enforced in 2012, with amendments in 2016. Thus, we elaborated the amended guidelines for the development of biosimilars.

Authors and Affiliations

Surbhi Gupta

Keywords

Related Articles

Role of biotechnology in industry and health care

Application of the field of Biotechnology has now become an integral part of every industrial organization involving diverse types of various industries, pharmaceuticals, agriculture, dairy, medicine, molecular genetics,...

Clinical profile of patients with alcoholic liver disease

Alcoholic liver disease (ALD) is a major cause of mortality and morbidity worldwide. Various studies show contradictory results about the role of amount, type and duration of alcohol exposure in determining the risk to d...

Method development and validation for simultaneous estimation of telmisartan and amlodipine by RP-HPLC

A novel, precise, accurate, rapid and effective isocratic RP-HPLC method was developed, optimized and validated for the estimation of Telimsartan (TEL) and Amlodipine (AML) in pharmaceutical dosage forms (tablet). The dr...

A study on antibiotic single dose efficacy and its prophylaxis in inguinal hernioplasty

Surgical site infection (SSI) is the most frequent complication in inguinal hernioplasty. SSI is related with an increase in length of stay and costs and a decrease in quality of life. Use of antibiotics in Lichtenstein’...

Investigation of phytochemical activities of saussurea lappa C.B. clarke root extract

The aim of the present study was to investigate the presence of phytochemical and Flavo- Glycosides in Ethonolic extract of Saussurea lappa. Saussurea lappa, a plant of the Asteraceae, one of the best-known species withi...

Download PDF file
  • EP ID EP203958
  • DOI -
  • Views 53
  • Downloads 0

How To Cite

Surbhi Gupta (2016). Regulations for the development of biosimilar. World Journal of Pharmaceutical Sciences, 4(11), 207-213. https://europub.co.uk/articles/-A-203958